Po-648-07 outcomes of infection in patients with implantable cardioverter defibrillators with end stage renal disease on hemodialysis

Implantable cardioverter defibrillators (ICDs) can be lifesaving devices in patients at risk for sudden cardiac death from ventricular arrhythmias. There is limited study of patients with ICDs and end-stage renal disease requiring dialysis in randomized trials. These patients are at risk for infection with a foreign device in the bloodstream, and at higher risk of infection given the need for hemodialysis. Data regarding ICD infection predictors, outcomes, and management are scarce.